Riskpilot← Back to searchSign inGet full accessNORDIC MEDICAL SOLUTIONS ApS
APSActiveCVR 34352542Axeltorv 2F, 5.Wholesale of pharmaceutical and medical goods · NACE 4646Est. 201216 employees
Revenue 2025
DKK 50,5M
+1% vs 2024
EBITDA margin
75.2%
-1% vs 2024
Equity ratio
52.4%
Financial strength
Net profit 2025
DKK 28,6M
-2% vs 2024
| Revenue | DKK 50,5M | +1% |
| EBITDA | DKK 38M | -1% |
| Net profit | DKK 28,6M | -2% |
| Total assets | DKK 71,7M | +6% |
| Equity | DKK 37,6M | +4% |
| Employees | 16 | — |
Legal name
NORDIC MEDICAL SOLUTIONS ApS
CVR number
34352542
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21. februar 2012
Share capital
DKK 80.000
Employees
16 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2025-06-30
Financial year
January – December
Signatory rights
Selskabet tegnes af bestyrelsesformanden i forening med den administrerende direktør, af bestyrelsesformanden i forening med ét bestyrelsesmedlem, af tre bestyrelsesmedlemmer i forening eller af den samlede bestyrelse.
Company purpose
Selskabets formål er - direkte eller via besiddelse af kapitalandele i andre selskaber - at drive handel med medicinsk udstyr og andre kosmetiske produkter og anden virksomhed, der efter bestyrelsens skøn er forbundet dermed.
Address
Axeltorv 2F, 5.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 55.667 | 51.393 | 45.366 | 50.098 | 50.531 |
| Staff expenses | -8.329 | -20.461 | -29.208 | -11.042 | -12.033 |
| EBITDA | 47.338 | 30.932 | 16.157 | 38.519 | 38.008 |
| Depreciation & amort. | -186 | -166 | -157 | -56 | -128 |
| EBIT | 47.152 | 30.766 | 16.000 | 38.463 | 37.880 |
| Net financials | -1.749 | -1.935 | -1.128 | -871 | -1.127 |
| Profit before tax | 45.403 | 28.831 | 14.872 | 37.592 | 36.753 |
| Tax | 10.054 | 6.620 | 3.343 | 8.317 | 8.138 |
| Net profit | 35.350 | 22.211 | 11.530 | 29.275 | 28.615 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 96.455 | 88.182 | 58.992 | 67.816 | 71.720 |
| Equity | 41.350 | 31.211 | 22.030 | 36.275 | 37.615 |
| Long-term debt | 10.110 | 6.623 | 15.050 | 8.304 | 7.983 |
| Short-term debt | 44.936 | 50.293 | 21.812 | 23.124 | 25.854 |
| Total debt | 55.046 | 56.916 | 36.862 | 31.428 | 33.837 |
EBITDA margin
75.2%
This company
15.8%
Market median
+376% vs market
20212025
Equity ratio
52.4%
This company
38.2%
Market median
+37% vs market
20212025
Return on equity
76.1%
This company
18.4%
Market median
+314% vs market
20212025
Net profit margin
56.6%
This company
8.1%
Market median
+599% vs market
20212025
Asset turnover
0.70×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.91×
This company
0.62×
Market median
+47% vs market
20212025
- Annual report 2025Filed via CVR / Virk · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via CVR / Virk · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via CVR / Virk · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via CVR / Virk · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via CVR / Virk · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
PW Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
CH Chief Executive Officer | Chief Executive Officer | 2017 – 2022 |
CG Management | Management | 2017 – 2017 |
HM Management | Management | 2022 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Board of Directors | 2022 | |
| Board of Directors | 2017 | |
| Chairman | 2015 | |
| Former (1) | ||
| Board of Directors | 2015 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2018 | |
| Company | 15–19.99% | 15–19.99% | 2017 | |
| Company | 10–14.99% | 10–14.99% | 2017 | |
| Company | 33.33–49.99% | 33.33–49.99% | 2017 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ginnerup Company ApS
NORDIC MEDICAL SOLUTIONS ApS Board members of NORDIC MEDICAL SOLUTIONS ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Pernille Wandrup Rex | Chief Executive Officer | 0 companies |
| Casper Henrique Tingkær | Chief Executive Officer | 0 companies |
| Carsten Gunnar Olesen | Management | 0 companies |
| Hilda Maria Nyhage | Management | 0 companies |
| Philip Schiermacher Stavnstrup | Board of Directors | 0 companies |
| Christa Bormann | Board of Directors | 0 companies |
| Monica Reib | Board of Directors | 0 companies |
| Kim Erik Ginnerup | Chairman | 0 companies |